KR100543980B1 - 2-(4-니트로페닐)설포닐에톡시카르보닐 치환된 아미노산유도체와 이의 제조방법 - Google Patents
2-(4-니트로페닐)설포닐에톡시카르보닐 치환된 아미노산유도체와 이의 제조방법 Download PDFInfo
- Publication number
- KR100543980B1 KR100543980B1 KR1020020051330A KR20020051330A KR100543980B1 KR 100543980 B1 KR100543980 B1 KR 100543980B1 KR 1020020051330 A KR1020020051330 A KR 1020020051330A KR 20020051330 A KR20020051330 A KR 20020051330A KR 100543980 B1 KR100543980 B1 KR 100543980B1
- Authority
- KR
- South Korea
- Prior art keywords
- group
- amino acid
- nitrophenyl
- nsc
- trt
- Prior art date
Links
- 150000003862 amino acid derivatives Chemical group 0.000 title claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 title claims abstract 4
- -1 2- (4-nitrophenyl) sulfonylethoxycarbonyl Chemical group 0.000 claims abstract description 40
- 238000000034 method Methods 0.000 claims abstract description 23
- 150000001413 amino acids Chemical class 0.000 claims abstract description 21
- 125000006239 protecting group Chemical group 0.000 claims abstract description 20
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims abstract description 18
- 238000010647 peptide synthesis reaction Methods 0.000 claims abstract description 16
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 15
- 125000003277 amino group Chemical group 0.000 claims abstract description 14
- 239000007790 solid phase Substances 0.000 claims abstract description 9
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims abstract description 7
- 239000000126 substance Substances 0.000 claims description 22
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 239000011347 resin Substances 0.000 claims description 6
- 229920005989 resin Polymers 0.000 claims description 6
- 230000002194 synthesizing effect Effects 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- 229960002317 succinimide Drugs 0.000 claims description 4
- 230000006103 sulfonylation Effects 0.000 claims description 3
- 238000005694 sulfonylation reaction Methods 0.000 claims description 3
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N anhydrous guanidine Natural products NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 49
- 238000003786 synthesis reaction Methods 0.000 abstract description 49
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 34
- 238000010511 deprotection reaction Methods 0.000 abstract description 15
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 15
- 238000010532 solid phase synthesis reaction Methods 0.000 abstract description 7
- 239000002253 acid Substances 0.000 abstract description 5
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 abstract description 5
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 abstract description 3
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 abstract description 2
- 150000003949 imides Chemical class 0.000 abstract description 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 102
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 99
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 86
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 85
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 73
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 56
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 54
- 229940024606 amino acid Drugs 0.000 description 51
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 44
- 238000006243 chemical reaction Methods 0.000 description 39
- 239000005457 ice water Substances 0.000 description 36
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 33
- 229960000583 acetic acid Drugs 0.000 description 29
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 27
- 239000012044 organic layer Substances 0.000 description 26
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 24
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 24
- 239000007787 solid Substances 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 19
- 229910052938 sodium sulfate Inorganic materials 0.000 description 19
- 235000011152 sodium sulphate Nutrition 0.000 description 19
- 238000004128 high performance liquid chromatography Methods 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 14
- 238000004821 distillation Methods 0.000 description 12
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 12
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 11
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 10
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 10
- 239000010410 layer Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 9
- 239000012267 brine Substances 0.000 description 9
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 8
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 229960004799 tryptophan Drugs 0.000 description 8
- 238000007086 side reaction Methods 0.000 description 7
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- 238000009833 condensation Methods 0.000 description 6
- 230000005494 condensation Effects 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 6
- 239000011734 sodium Substances 0.000 description 5
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 4
- JFLSOKIMYBSASW-UHFFFAOYSA-N 1-chloro-2-[chloro(diphenyl)methyl]benzene Chemical compound ClC1=CC=CC=C1C(Cl)(C=1C=CC=CC=1)C1=CC=CC=C1 JFLSOKIMYBSASW-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- LZTRCELOJRDYMQ-UHFFFAOYSA-N triphenylmethanol Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(O)C1=CC=CC=C1 LZTRCELOJRDYMQ-UHFFFAOYSA-N 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
- 239000004473 Threonine Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 238000006277 sulfonation reaction Methods 0.000 description 3
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 3
- 229960002898 threonine Drugs 0.000 description 3
- 229960004441 tyrosine Drugs 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- VUTZFAOGDXUYEJ-UHFFFAOYSA-N 1-[chloro(diphenyl)methyl]-4-methylbenzene Chemical compound C1=CC(C)=CC=C1C(Cl)(C=1C=CC=CC=1)C1=CC=CC=C1 VUTZFAOGDXUYEJ-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 2
- ZMQBBPRAZLACCW-UHFFFAOYSA-N acetic acid;dichloromethane Chemical compound ClCCl.CC(O)=O ZMQBBPRAZLACCW-UHFFFAOYSA-N 0.000 description 2
- 239000003377 acid catalyst Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- FDJUMMKAFUMWBI-UHFFFAOYSA-N chloro carbonochloridate Chemical compound ClOC(Cl)=O FDJUMMKAFUMWBI-UHFFFAOYSA-N 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000006642 detritylation reaction Methods 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- WYYVJRBSJGUXSL-JKSHRDEXSA-N diethylazanium;(2s,3r)-3-hydroxy-2-(tritylamino)butanoate Chemical compound CCNCC.C=1C=CC=CC=1C(C=1C=CC=CC=1)(N[C@@H]([C@H](O)C)C(O)=O)C1=CC=CC=C1 WYYVJRBSJGUXSL-JKSHRDEXSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 229960003646 lysine Drugs 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- VYMPLPIFKRHAAC-UHFFFAOYSA-N 1,2-ethanedithiol Chemical compound SCCS VYMPLPIFKRHAAC-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 229920000361 Poly(styrene)-block-poly(ethylene glycol) Polymers 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 150000001483 arginine derivatives Chemical class 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960003773 calcitonin (salmon synthetic) Drugs 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012039 electrophile Substances 0.000 description 1
- 238000010931 ester hydrolysis Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960005337 lysine hydrochloride Drugs 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- TVHCXXXXQNWQLP-DMTCNVIQSA-N methyl (2s,3r)-2-amino-3-hydroxybutanoate Chemical compound COC(=O)[C@@H](N)[C@@H](C)O TVHCXXXXQNWQLP-DMTCNVIQSA-N 0.000 description 1
- MWZPENIJLUWBSY-VIFPVBQESA-N methyl L-tyrosinate Chemical compound COC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MWZPENIJLUWBSY-VIFPVBQESA-N 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- FIQUJFFZRPEKGF-UHFFFAOYSA-N n-ethyl-n-tritylethanamine Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(N(CC)CC)C1=CC=CC=C1 FIQUJFFZRPEKGF-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- QCMHWZUFWLOOGI-UHFFFAOYSA-N s-ethyl chloromethanethioate Chemical compound CCSC(Cl)=O QCMHWZUFWLOOGI-UHFFFAOYSA-N 0.000 description 1
- 108010068072 salmon calcitonin Proteins 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- WGWPRVFKDLAUQJ-MITYVQBRSA-N sermorelin Chemical compound C([C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)C1=CC=C(O)C=C1 WGWPRVFKDLAUQJ-MITYVQBRSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
펩티드 | 탈보호 조건(%) | 시간 (분) | 펩티드 | 순도 (%) |
1-a | TFA/CH2Cl2= 50/50 | 90 | Nsc-Ser-Met-Ser-Met-Ser-OH (Nsc/tBu 이용) | 56 |
TFA/TIS/H2O = 95/2.5/2.5 | 120 | 35 | ||
TFA/H2O/EDT/TIS = 94.5/2.5/2.5/2.5/1 | 120 | 67 | ||
1-b | TFA/CH2Cl2= 50/50 | 90 | Nsc-Ser-Met-Ser-Met-Ser-OH (Nsc/trt 이용) | 95 |
TFA/CH2Cl2= 5/95 | 15 | 93 | ||
TFA/TIS/H2O = 95/2.5/2.5 | 120 | 83 | ||
TFA/H2O/EDT/TIS = 94.5/2.5/2.5/2.5/1 | 120 | 81 | ||
2-a | TFA/CH2Cl2= 50/50 | 90 | Nsc-Ser-Trp-Ser-Trp-Ser-OH (Nsc/tBu 이용) | 70 |
TFA/TIS/H2O = 95/2.5/2.5 | 120 | 35 | ||
TFA/H2O/EDT/TIS = 94.5/2.5/2.5/2.5/1 | 120 | 48 | ||
2-b | TFA/CH2Cl2= 50/50 | 90 | Nsc-Ser-Trp-Ser-Trp-Ser-OH (Nsc/trt 이용) | 87 |
TFA/CH2Cl2= 5/95 | 15 | 93 | ||
CH2Cl2/TFA/TIS =94/1/5 | 30 | 93 | ||
TFA/TIS/H2O = 95/2.5/2.5 | 120 | 56 | ||
TFA/H2O/EDT/TIS = 94.5/2.5/2.5/2.5/1 | 120 | 65 | ||
3-a | TFA/CH2Cl2= 50/50 | 120 | H-Thr-Thr-Trp-Thr-Ser-Met-Ser-Trp-Tyr-OH (Nsc/tBu 이용) | 25 |
TFA/TIS/H2O = 95/2.5/2.5 | 120 | 22 | ||
TFA/H2O/EDT/TIS = 94.5/2.5/2.5/2.5/1 | 120 | 60 | ||
3-b | TFA/CH2Cl2= 50/50 | 15 | H-Thr-Thr-Trp-Thr-Ser-Met-Ser-Trp-Tyr-OH (Nsc/trt 이용) | 81 |
TFA/TIS/H2O = 95/2.5/2.5 | 120 | 69 | ||
TFA/H2O/EDT/TIS = 94.5/2.5/2.5/2.5/1 | 120 | 66 | ||
TFA/CH2Cl2= 5/95 | 15 | 95 | ||
CH2Cl2/TFA/TIS = 94/1/5 | 30 | 83 |
Claims (6)
- 다음 화학식 1로 표시되는 것임을 특징으로 하는 2-(4-니트로페닐)설포닐에톡시카르보닐 치환된 아미노산 유도체 :[화학식 1]상기 화학식 1에서,R1는 수소원자, -OR 또는 -NHR을 나타내고; R2은 수소원자, 치환 또는 비치환된 C1∼C6의 알킬기, 치환 또는 비치환된 페닐기, 또는 를 나타내며, 이때 치환기는 -OR, -NHR 또는 -NHC(=NH)NHR을 나타내고; R은 보호기로서 트리틸기, 할로트리틸기, C1∼C6의 알킬 치환된 트리틸기, 또는 t-부티록시카르보닐기를 나타내고,단, R1이 수소원자이고, R2가 OR로 치환된 C1∼C6의 알킬기 또는 페닐기이고, R가 t-부티록시카르보닐기인 화합물은 제외한다.
- 제 1 항에 있어서, 상기 화학식 1에서 R은 트리틸기(-trt), 2-클로로트리틸기(2-Cltrt), 메틸트리틸기(-Mtt) 또는 t-부티록시카르보닐기(t-Boc)인 것임을 특징으로 하는 2-(4-니트로페닐)설포닐에톡시카르보닐 치환된 아미노산 유도체.
- 제 1 항에 있어서, 상기 화학식 1에서 -CHR1R2은 CH2O-Trt, -CH(O-Trt)CH 3, -CH2C6H4O-Trt, -CH2C6H4O-(2-Cltrt), -CH2CH2CH2CH2NH-Trt, -CH2CH2CH2 CH2NH-Mtt, -CH2CH2CH2NHC(=NH)NH-Trt, 또는 -CH2-인돌-N-t-Boc 인 것임을 특징으로 하는 2-(4-니트로페닐)설포닐에톡시카르보닐 치환된 아미노산 유도체.
- 다음 화학식 2a로 표시되는 2-(4-니트로페닐)설포닐에톡시카르보닐 N-숙신이미드(Nsc-Osu)와 다음 화학식 3a로 표시되는 아미노산 단분자를 반응시켜 다음 화학식 4a로 표시되는 2-(4-니트로페닐)설포닐에톡시카르보닐-아미노산(Nsc-아미노산)을 합성하는 과정, 그리고상기에서 제조한 화학식 4a로 표시되는 Nsc-아미노산의 곁사슬로 위치하는 하이드록시기(-OH) 또는 아민기(-NH2)에 보호기(R)를 도입하여 다음 화학식 1로 표시되는 2-(4-니트로페닐)설포닐에톡시카르보닐 치환된 아미노산 유도체를 합성하는 과정이 포함되는 것을 특징으로 하는 제조방법 :
- 다음 화학식 2b로 표시되는 2-(4-니트로페닐)사이오에톡시카르보닐 클로라이드("Ntc-Cl")와 다음 화학식 3b로 표시되는 아미노산 알킬 에스테르 단분자를 반응시켜 다음 화학식 4b로 표시되는 2-(4-니트로페닐)사이오에톡시카르보닐-아미노산 에스테르("Ntc-아미노산 에스테르")를 합성하는 과정과,상기에서 제조한 화학식 4b로 표시되는 Ntc-아미노산 에스테르의 곁사슬로 위치하는 하이드록시기(-OH) 또는 아민기(-NH2)에 보호기(R)를 도입한 후에 에스테르 가수분해하여 다음 화학식 5로 표시되는 2-(4-니트로페닐)사이오에톡시카르보닐-아미노산("Ntc-아미노산")을 제조하는 과정과, 그리고상기에서 제조한 화학식 5로 표시되는 Ntc-아미노산을 설포닐화 반응하여 다음 화학식 1로 표시되는 2-(4-니트로페닐)설포닐에톡시카르보닐 치환된 아미노산 유도체를 합성하는 과정이 포함되는 것을 특징으로 하는 제조방법 :상기에서, R1, R2, R' 및 R"는 각각 상기 청구항 4에서 정의한 바와 같다.
- 다음 화학식 1로 표시되는 2-(4-니트로페닐)설포닐에톡시카르보닐 치환된 아미노산 유도체가 결합되어 있는 수지를 사용하는 것을 특징으로 하는 고체상 펩티드 합성법 :[화학식 1]상기 화학식 1에서,R1는 수소원자, -OR 또는 -NHR을 나타내고; R2은 수소원자, 치환 또는 비치환된 C1∼C6의 알킬기, 치환 또는 비치환된 페닐기, 또는 를 나타내며, 이때 치환기는 -OR, -NHR 또는 -NHC(=NH)NHR을 나타내고; R은 보호기로서 트리틸기, 할로트리틸기, C1∼C6의 알킬 치환된 트리틸기, 또는 t-부티록시카르보닐기를 나타내고,단, R1이 수소원자이고, R2가 OR로 치환된 C1∼C6의 알킬기 또는 페닐기이고, R가 t-부티록시카르보닐기인 화합물은 제외한다.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020051330A KR100543980B1 (ko) | 2002-08-29 | 2002-08-29 | 2-(4-니트로페닐)설포닐에톡시카르보닐 치환된 아미노산유도체와 이의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020051330A KR100543980B1 (ko) | 2002-08-29 | 2002-08-29 | 2-(4-니트로페닐)설포닐에톡시카르보닐 치환된 아미노산유도체와 이의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040021727A KR20040021727A (ko) | 2004-03-11 |
KR100543980B1 true KR100543980B1 (ko) | 2006-01-20 |
Family
ID=37325721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020020051330A KR100543980B1 (ko) | 2002-08-29 | 2002-08-29 | 2-(4-니트로페닐)설포닐에톡시카르보닐 치환된 아미노산유도체와 이의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100543980B1 (ko) |
-
2002
- 2002-08-29 KR KR1020020051330A patent/KR100543980B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20040021727A (ko) | 2004-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6350632B2 (ja) | ペプチドの製造方法 | |
US5977302A (en) | Liquid phase process for the preparation of GnRH peptides | |
EP2181118A1 (en) | Process for the production of pramlintide | |
EP1870411A1 (en) | Process for the preparation and purification of valgancyclovir | |
JP2023007947A (ja) | 液相ペプチド製造方法 | |
AU2016260693A1 (en) | Process for preparation of nitrogen mustard derivatives | |
WO2022115825A1 (en) | Compositions and methods for chemical synthesis | |
KR100863394B1 (ko) | 페린도프릴 및 이의 약학적으로 허용되는 염의 합성 방법 | |
US5166394A (en) | Coupling reagent for peptide synthesis | |
US4954616A (en) | Use of guanidine-related compounds comprising a substituted tetraphenylborate ion in solution phase peptide synthesis | |
WO2021109297A1 (zh) | 一种依特卡肽中间体及依特卡肽的合成方法 | |
SE452318B (sv) | Aminosyror till anvendning som mellanprodukter vid framstellning av bestatiner | |
KR100543980B1 (ko) | 2-(4-니트로페닐)설포닐에톡시카르보닐 치환된 아미노산유도체와 이의 제조방법 | |
JP7278775B2 (ja) | 長鎖化合物の製造方法 | |
WO2021026800A1 (zh) | 醋酸地加瑞克的合成方法 | |
US5506362A (en) | Process for the preparation of an α-amino acid amide | |
JP4407322B2 (ja) | ペプチドの製造方法 | |
US5212287A (en) | Pentapeptide synthesis | |
KR20080037422A (ko) | 2-(4-니트로페닐)설포닐에톡시카르보닐 치환된 n-알킬아미노산 유도체와 이의 제조방법 | |
EP1546186A1 (en) | Method for synthesizing peptides | |
SHIN et al. | Dehydrooligopeptides. IV. Synthesis of Various Types of Dehydrodi-and tripeptides by Fragment Condensation and Base-Catalyzed β-Elimination | |
JP2748897B2 (ja) | 新規なアルギニン誘導体およびこれを用いるペプチドの製造方法 | |
KR100272310B1 (ko) | 액상 1-데아미노-8-d-아르기닌 바소프레신 아세테이트 합성법 | |
CN116410260A (zh) | 一种Fmoc-L-Orn(Boc)-Gly-OH及其制备方法和应用 | |
JPH0511105B2 (ko) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130107 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140107 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150113 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160112 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20161229 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180104 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190104 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20191210 Year of fee payment: 15 |